Additional value of PSMA-PET/CT in biochemical recurrence during follow-up of patients with prostate cancer [Abstract]
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Nuclear Medicine, 56, Supplement 3, S. 1439-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2015
- Ereignis
-
Veröffentlichung
- (wo)
-
New York, NY
- (wer)
-
Society of Nuclear Medicine
- (wann)
-
2015
- Urheber
-
Bluemel, Christina
Christian, Vollmer
Buck, Andreas
Lapa, Constantin Frederik Victor
Riedmiller, Hubertus
Lassmann, Michael
Schirbel, Andreas
Herrmann, Ken
- URN
-
urn:nbn:de:bvb:384-opus4-637097
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bluemel, Christina
- Christian, Vollmer
- Buck, Andreas
- Lapa, Constantin Frederik Victor
- Riedmiller, Hubertus
- Lassmann, Michael
- Schirbel, Andreas
- Herrmann, Ken
- Universität Augsburg
- Society of Nuclear Medicine
Entstanden
- 2015
Ähnliche Objekte (12)
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging"
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography
In vivo targeting of CXCR4 - new horizons
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging"
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography
In vivo targeting of CXCR4 - new horizons
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging"
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography